Ladenburg Thalmann Downgrades CONMED (CNMD) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- US stock futures gain as oil pulls back ahead of Fed decision
- Nvidia to commit $3 bln to Meta share offering as part of bigger AI partnership
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $47.68 --0%
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 16
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 16
Join SI Premium – FREE
Ladenburg Thalmann downgraded CONMED (NASDAQ: CNMD) from Buy to Neutral with a price target of $55 (unchanged).
For an analyst ratings summary and ratings history on CONMED click here. For more ratings news on CONMED click here.
Shares of CONMED closed at $54.23 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Keefe, Bruyette & Woods Downgrades Bank of Hawaii (BOH) to Market Perform, 'Risk/Reward More Balanced in the Current Backdrop'
- Scotiabank Downgrades Logan Energy Corp (LGN:CN) (LOECF) to Sector Perform
- Stephens Downgrades Varonis Systems (VRNS) to Equal Weight
Create E-mail Alert Related Categories
DowngradesRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
